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The use of programmed stimulation to assess long-term oral 
antiarrhythmic drug efficacy for ventricular tachycardia is 
complicated by the fact that mode of ventricular tachycar- 
dia induction varies from day to day in the absence of drug 
therapy. The purpose of this prospective study was to assess 
whether mode of ventricular tachycardia induction is more 
reproducible within one study than from day to day. 
Thirty-nine consecutive patients with documented sus- 
tained ventricular tachyarrhythmias secondary to coronary 
artery disease underwent three inductions of ventricular 
tachycardia at 15 min intervals in the absence of drug 
therapy. A stimulation protocol in which the only major 
variable was the number of extrastimuli required for 
tachycardia induction was used. Subsequent day to day 
variability in mode of tachycardia induction was also 
assessed in the same patients at two further drug-free 
inductions at intervals of 5 f 2 days. 
The number of extrastimuli required for tachycardia 
induction was significantly more reproducible at the imme- 
diate repeat studies than from day to day (69% of patients 
versus 31%) p < 0.01). From these data, probability tables 
were derived that show the likelihood that changes in 
inducibility at subsequent tachycardia inductions are due to 
chance. The QRS configuration of induced ventricular 
tachycardia was also more reproducible at the immediate 
studies (64% versus 26%) p < 0.01). Basic electrophysio- 
logic and stimulation variables differed over a significantly 
wider range from day to day than at the immediate studies. 
These findings suggest that short-term intravenous anti- 
arrhythmic drug testing at electrophysiologic study should 
be more accurate than testing of oral drug therapy when 
drugs with similar pharmacodynamic effects by either route 
are used. The probability tables constructed from these 
data should permit drug-related changes in inducibility to 
be identified with a 95% accuracy for antiarrhythmic 
effects and a 80% accuracy for proarrhythmic effects. 
(J Am Co11 Cardiol1989;13:1599-607) 
The mode of induction of ventricular tachycardia frequently 
varies from day to day when patients with inducible ventric- 
ular tachycardia secondary to coronary artery disease are 
studied in the absence of antiarrhythmic drug therapy (1,2). 
Using the number of extrastimuli required for ventricular 
tachycardia induction as a quantitative index of ease of 
arrhythmia induction. we have previously shown (3) that the 
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95% confidence interval for this day to day variability is a 
sizable 2 1 extrastimulus. Variability to this degree may 
interfere with assessment of oral antiarrhythmic drug ef- 
ficacy at electrophysiologic testing because several days 
usually elapse between the control study and repeat studies 
on therapy (4-7). 
However, electrophysiologic drug testing for ventricular 
tachycardia has also been performed with the use of short- 
term intravenous drug administration @--lo), in which case 
allowance for immediate or within-study variability in mode 
of arrhythmia induction may also be crucial to the accurate 
assessment of drug efficacy. We postulated that variability 
within one study might be less than that in studies that are 
performed days apart. The purpose of this prospective study 
was to compare immediate and day to day variability in 
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Table 1. Clinical Characteristics of 39 Patients 
Age (yr) 
Gender 
Male 
Female 
Radionuclide ejection fraction (%) 
Presenting arrhythmia 
Ventricular tachycardia 
Ventricular fibrillation 
Both 
Median number of arrhythmia episodes 
per patient 
Median interval between last AM1 and 
first arrhythmia episode (wk) 
60 + 10 
(range 30 to 73) 
34 
5 
29 + 9 
28 
3 
8 
4 
(range 1 to 112) 
9 
AMI = acute myocardial infarction. 
ventricular tachycardia induction in the same patient group 
in the drug-free state. 
Methods 
Study patients. The initial study group consisted of 47 
consecutive patients who fulfilled the following entry crite- 
ria: 1) Documented sustained (> 10 s) ventricular tachycardia 
or fibrillation occurring >5 days after prior acute myocardial 
infarction in the absence of further ischemia, electrolyte 
imbalance or drug toxicity. 2) Angiographically documented 
significant coronary artery disease defined as 250% luminal 
diameter narrowing. 3) Age 175 years. 4) Sufficient freedom 
from arrhythmia and other life-threatening disease to allow 
antiarrhythmic drug withdrawal and serial electrophysiolog- 
ic studies. 5) Provision of written informed consent. 
Eight patients did not complete the study protocol and 
were excluded from analysis. The reasons for withdrawal 
were withdrawal of consent after initial electrophysiologic 
study (three patients); fatal cerebrovascular accident occur- 
ring in the interim between electrophysiologic studies (one 
patient); physician choice (one patient); the occurrence of 
atria1 fibrillation with a rapid ventricular rate during an 
electrophysiologic study precluding completion of the base- 
line ventricular tachycardia induction protocol (one patient); 
and noninducibility of a ventricular tachyarrhythmia (two 
patients). These latter two patients had each survived prior 
cardiac arrests at which ventricular fibrillation had been 
documented, but no ventricular tachyarrhythmia was induc- 
ible when a stimulation protocol including four extrastimuli 
was employed. 
The clinical characteristics of the remaining 39 patients 
are summarized in Table 1. The study was approved by the 
Research and Ethics Committees of the Parramatta Hospi- 
tals on August 28, 1984. 
Study design. Immediate reproducibility of ventricular 
tachycardia induction was assessed in each patient after all 
antiarrhythmic medications including beta-adrenergic block- 
ers and verapamil had been withdrawn for 25 days. At this 
initial off-drugs study, programmed ventricular stimulation 
was performed in each patient on three occasions at intervals 
of 15 min. 
The same stimulation protocol was employed for each of 
the three inductions. At repeat inductions, the entire proto- 
col was repeated rather than simply repeating the particular 
step that had induced tachycardia on the previous occasion. 
Three inductions were performed in each patient irrespec- 
tive of the need to terminate induced arrhythmias with 
external cardioversion. No antiarrhythmic drugs were tested 
at this initial study. 
Day to day reproducibility was then assessed in the same 
patients at two further off-drugs electrophysiologic studies 
performed on separate days at a mean interval of 5 2 2 days. 
At each of these studies, a single baseline induction of 
ventricular tachycardia was attempted after which an anti- 
arrhythmic drug was administered intravenously. The ab- 
sence of the previously tested drug was confirmed by serum 
level assays at the commencement of the third study. 
Therefore, a total ofJive inductions of ventricular tachy- 
cardia was performed in each patient in the absence of 
antiarrhythmic drug therapy. The first induction of ventric- 
ular tachycardia was compared with two repeat inductions 
on the same day, as well as with two repeat inductions on 
separate days. 
Electrophysiologic studies. Each patient fasted and was 
premeditated with 10 mg oral diazepam. Heparin, 5,000 U, 
was administered intravenously at the commencement of 
each study. One percent lidocaine was used for local anes- 
thesia and serum for determining lidocaine levels was ob- 
tained immediately after each ventricular tachycardia induc- 
tion. At the first electrophysiologic study, two quadripolar 
and one tripolar 6F electrode catheters were introduced 
percutaneously through the right femoral vein and posi- 
tioned under fluoroscopic guidance at the high right atrium, 
right ventricular apex and the His bundle region, respec- 
tively. Standard assessments of anterograde and retrograde 
atrioventricular conduction were performed at this first 
study before the ventricular tachycardia induction protocol 
was started. 
Pacing catheter position was not altered during the as- 
sessment of immediate reproducibility of tachycardia induc- 
tion. Catheters were removed at the conclusion of this initial 
study and a single quadripolar catheter was reinserted and 
positioned at the right ventricular apex at each of the 
subsequent studies on separate days. Intracardiac record- 
ings and three orthogonal surface electrocardiographic leads 
(Frank leads X, Y and Z) were recorded simultaneously on a 
Siemens-Elema Mingograf 804 at paper speeds of 50 to 100 
mm/s. Programmed stimulation was performed with a stim- 
ulator (WP Instruments) delivering rectangular pulses 2 ms 
in duration. 
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Stimulation protocol. The protocol of programmed ven- 
tricular stimulation employed in this study has been previ- 
ously described (3). Programmed stimulation was performed 
at a single site, the right ventricular apex, at twice diastolic 
threshold. Extrastimuli were introduced after a stable 8 beat 
ventricular drive train with a single basic pacing cycle length 
as close as practical to 600 ms. A three second pause was 
programmed between successive drive trains. Multiple drive 
train cycle lengths and burst pacing were not employed. 
Delivery of extrastimuli began at an initial coupling interval 
of 300 ms, which was decreased in 10 ms steps until 
ventricular refractoriness was encountered or a ventricular 
tachyarrhythmia was induced. Each particular extrastimulus 
coupling interval was delivered 3 times if no tachycardia was 
induced, before decrementing by 10 ms. This is the tech- 
nique of “lateral” repetition of extrastimulus coupling inter- 
vals (11). Previously we have shown (11) that such repetition 
does not affect day to day variability in mode of tachycardia 
induction, but may reduce the incidence of induction of 
unwanted ventricular fibrillation. 
When the right ventricular effective refractory period was 
encountered with an extrastimulus, that extrastimulus was 
placed 10 ms above refractoriness and a further extrastimu- 
lus was added. Up to seven extrastimuli were available with 
the programmable stimulator used in this study, although the 
maximal number actually required for tachycardia induction 
in any study was five. The end-point of stimulation was 
induction of more than 10 s of ventricular tachycardia or 
fibrillation. Induced tachycardias were terminated by burst 
pacing or direct current cardioversion. 
Comparison of induced tachycardias. Induced tachycar- 
rhythmias were compared with the use of previously pub- 
lished criteria (3). To be classified as similar, two induced 
tachycardias had to fulfill both of the following criteria for 
cycle length and QRS configuration: 1) Cycle lengths within 
50 ms of each other; and 2) similar bundle branch block-like 
pattern in lead Z of the Frank vectorcardiogram and mean 
frontal plane QRS axes within 45” of each other. 
Statistical analyses. Student’s paired t test was used to 
compare group means for continuous variables. Multiple 
studies in the same patient group were compared with a 
two-way analysis of variance. Differences between individ- 
ual studies were then examined using the paired t test with 
the Bonferroni adjustment. 
Ninety-five percent confidence intervals for study to 
study variability in cycle length of induced tachycardias 
were derived from the residual mean square at two-way 
analysis of variance of the tachycardia cycle lengths at each 
study. The square root of the mean square of the residual 
error was taken as the standard deviation for study to study 
variability, and 95% intervals were constructed by doubling 
this standard deviation. 
McNemar’s test for correlated proportions was used to 
compare the proportion of patients who had variations 
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Figure 1. Histograms illustrating the cumulative percentage and 
number (n) of patients in whom a ventricular tachyarrhythmia (VT) 
was induced with each successive extrastimulus at the initial 
arrhythmia induction. 
within one study versus those who had variations in studies 
on separate days (12). The chi-square test was used to 
compare independent proportions. 
The probability that the same or different numbers of 
extrastimuli were required in either of the two repeat induc- 
tion studies in patients who had arrhythmia induced with 1, 
2. 3 or 4 extrastimuli at the initial baseline study was 
displayed in tables that we have termed probability matrices. 
A probability value co.05 was considered significant. All 
values are expressed as mean 2 1 SD. except where indi- 
cated. 
Results 
Immediate reproducibility of mode of tachycardia induc- 
tion. At the first electrophysiologic study, three separate 
inductions of ventricular tachycardia were performed in 
each patient at 15 min intervals. A sustained ventricular 
tachyarrhythmia was inducible at these three inductions in 
all patients. The mean number of extrastimuli required for 
tachycardia induction was 2.3 * 0.8, and the median dura- 
tion of induced ventricular tachyarrhythmias was 25 s. 
Direct current cardioversion was required for arrhythmia 
termination in 40 inductions (34%). with a shock %I50 J 
being effective in 33 inductions. The cumulative percentage 
of tachyarrhythmias induced with each successive extrastim- 
ulus at the first induction attempt is illustrated in Figure 1. 
Variability in mode of tachycardia induction was ob- 
served in 12 patients (31%) over the course of these three 
inductions, and in 10 patients (26%) if only the first two 
inductions were considered (p = NS). Compared with the 
initial induction attempt, fewer extrastimuli were required 
during at least one subsequent induction in seven patients 
(18%) and more extrastimuli in three patients (8%); variation 
in both directions was observed in the remaining two pa- 
tients. In 10 patients the results varied by 1 extrastimulus, 
and in two patients they varied by 2 extrastimuli. 
The mode of ventricular tachycardia induction varied 
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SUBSEQUENT NO. OF EXTRASTIMULI 
Figure 2. Matrix illustrating the probability of a ventricular tachy- 
arrhythmia being induced with the same or different number (No.) of 
extrastimuli at repeat inductions in the one study, e.g., if ventricular 
tachycardia was induced with one extrastimulus at an initial attempt 
then the probability of ventricular tachycardia being induced again 
with one extrastimulus at a second attempt is 0.70. and the proba- 
bility of requiring two extrastimuli is 0.30. The line of identity is 
indicated by the hatched squares. On the basis of these data, a move 
from the line of identity into the shaded area on the right after drug 
administration would constitute a change in tachycardia induction 
requirements that has a 95% probability of being due to the 
administered drug. A move to the shaded area on the left would 
indicate a 90% probability that the change was due to a drug effect. 
N = number of repeat studies on which the probability values were 
based (two studies per patient = 78). 
more frequently in those patients who required 3 or 4 
extrastimuli at the initial attempt than in those who had 
inducible tachycardia with 12 extrastimuli (50% versus 17010, 
p < 0.05). A probability matrix based on the degree of 
variability observed at subsequent ventricular tachycardia 
inductions is illustrated in Figure 2. 
Apart from a slight shortening of the sinus cycle length 
and basic pacing cycle length, baseline electrophysiologic 
variables for the whole group were essentially stable over 
the course of the three inductions, (Table 2). As expected, 
serum levels of lidocaine, which was used for local anesthe- 
sia, decreased progressively over the course of the three 
inductions. 
There were also no systematic differences in these base- 
line variables over time between those patients whose induc- 
tion requirements varied and those whose induction mode 
was reproducible. Sinus cycle length and, consequently, 
basic pacing cycle length shortened slightly over the course 
of the three inductions in each group. There were no 
significant changes in corrected QT interval, stimulation 
threshold or right ventricular effective refractory period over 
time in either patient subgroup. Serum lidocaine levels 
declined significantly over the three inductions in those 
patients whose induction mode did not vary. In those 
patients whose mode of induction changed, mean serum 
lidocaine levels also decreased from 5.6 pmollliter at the first 
tachycardia induction to 4.6 pmollliter after the third induc- 
tion, but in this small patient group the difference was not 
statistically significant. 
Immediate variability in rate and configuration of induced 
tachycardia. Monomorphic ventricular tachycardia was the 
end point of stimulation at the first induction attempt in 35 
patients (90%); it remained inducible at the two subsequent 
inductions in 33 (94%) of these patients. In two patients 
(6%), ventricular fibrillation was induced at one of the repeat 
inductions. 
In four patients, either ventricular$brillation orpolymor- 
phic ventricular tachycardia was the end point of stimulation 
at the first induction attempt, and ventricular fibrillation 
remained inducible at the two subsequent inductions in three 
of these patients (75%). Monomorphic ventricular tachycar- 
dia was induced during one subsequent induction attempt in 
the remaining patient. 
The mean cycle length of induced monomorphic ventric- 
ular tachycardia was 281 t- 55 ms. For those patients in 
whom monomorphic ventricular tachycardia was induced at 
all three induction attempts, the 95% confidence interval for 
variation in tachycardia cycle length, determined from anal- 
Table 2. Baseline Variables for the Immediate Studies 
P 
Study 1 Study 2 Study 3 F Value 
SCL (ms) 125 + 127 689 k 110 680 + 116 9.85 <O.ool 
BCL (ms) 55-l t 46 545 f 48 539 + 48 13.79 <O.ool 
QTc (ms) 449 r 40 451 + 43 455 ? 46 1.25 NS 
VERP (ms) 245 2 20 244 + 22 241 ? 21 2.31 NS 
Threshold (mA) 1.2 + 0.4 1.2 t 0.4 1.2 + 0.4 1 .oo NS 
Serum lidocaine post-VT 624 5?2 4+3 1.15 <o.oos 
(pmoliliter) 
Values are expressed as mean + SD. The therapeutic range for lidocaine was 4 to 26 kmol/liter. BCL = basic 
pacing drive train cycle length; F = F value obtained at analysis of variance for “between studies” source of 
variance; NS = not significant at 0.05 level: post-VT = immediately after termination of induced ventricular 
tachycardia; QTc = corrected QT interval using formula QT/Vk interval; SCL = sinus cycle length; VERP = right 
ventricular effective refractory period as determined with the first extrastimulus (S,). 
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Table 3. Comparison of Immediate Versus Day to Day Variability in Ventricular 
Tachycardia Induction 
Variability in mode of VT induction 
(% of pts) 
Multiple distinct configurations of 
induced VT (% of pts) 
Keproducible cycle length of 
induced VT (550 ms) 
Reproducibility of monomorphic 
VT as end point of stimulation 
Immediate Day to Day 
Studies Studies 
31% 69% 
36% 74% 
85% 19% 
94% 83% 
P 
Value 
10.01 
<O.OOl 
NS 
NS 
pts = patients: VT = ventricular tachyarrhythmia. 
ysis of variance, was 233 ms. The maximal range of varia- 
tion in cycle length observed in any patient over three 
inductions was 100 ms. 
Different configurations of ventricular tachycardia were 
induced at repeat induction studies in 14 patients (36%). 
This variation in the configuration of induced ventricular 
tachycardias did not correlate with variability in mode of 
tachycardia induction. Hence, the mode of tachycardia 
induction varied in eight (32%) of the 25 patients in whom a 
similar ventricular tachycardia configuration was induced at 
each of three attempts. 
Comparison of arrhythmia induction at immediate and day 
to day studies (Table 3). The initial induction of ventricular 
tachycardia on day 1 was also compared with two further 
drug-free inductions on separate days. The mean interval 
between the first and second studies was 5 * 2 days, and that 
between the second and third studies was 6 t 2 days (p = 
NS). 
A sustained ventricular tachyarrhythmia was again in- 
duced in all patients at these two further studies. The mean 
number of extrastimuli required for ventricular tachycardia 
induction from day to day was 2.3 ? 0.8 (p = NS compared 
with the immediate studies). The median duration of induced 
tachyarrhythmias was 24 s, and external countershock was 
required for arrhythmia termination in 37 studies (32%). The 
mode of induction of ventricular tachycardia was signifi- 
cantly more reproducible at the immediate studies than from 
day to day. In contrast to the immediate studies, the inci- 
dence of day to day variability in mode of ventricular 
tachycardia induction was similar for all patients irrespective 
of the number of extrastimuli required at the first induction. 
A probability matrix based on the observed day to day 
variability in the number of extrastimuli inducing ventricular 
tachycardia is illustrated in Figure 3. 
The range of variability in cycle lengths of induced 
monomorphic ventricular tachycardias was not significantly 
different for the immediate and day to day studies (mean of 
18 ms versus 23 ms, p = 0.34). The 95% confidence interval 
for day to day variability in cycle length of induced mono- 
morphic ventricular tachycardias was t-35 ms, which was 
similar to that of the immediate studies. Ventricular fibrilla- 
tion was induced on 1 subsequent day in 6 (17%) of the 35 
patients in whom monomorphic ventricular tachycardia was 
induced at the first attempt (p = NS compared with the 
immediate studies). 
Factors influencing variability. Patients with a lower ejec- 
tion fraction and patients in whom fewer extrastimuli were 
required for ventricular tachycardia induction displayed less 
variability in mode of arrhythmia induction at the immediate 
repeat studies. However, the differences were slight: radio- 
nuclide ejection fraction was 27 t 8% in patients whose 
induction requirements did not vary on a short-term basis 
versus 32 t 10% in the remainder (p = 0.04); and the mean 
number of extrastimuli inducing ventricular tachycardia was 
2.2 ? 0.6 in those patients in whom mode of induction did 
not vary versus 2.7 ? 1.0 extrastimuli in the remaining 
patients (p = 0.04). Hence, these clinical criteria did not 
provide a useful means of predicting which patients were 
likely to display immediate variability in ventricular tachy- 
cardia induction requirements. Other clinical characteristics 
also did not distinguish between those patients whose induc- 
tion requirements varied from day to day and those in whom 
mode of induction was reproducible. 
Figure 3. Matrix illustrating the probability of a change in ventricular 
tachycardia induction requirements at a repeat study on a subse- 
quent day compared with an initial baseline study. Format is similar 
to that of Figure 2. 
SUBSEQUENT NO. OF EXTRASTIMULI 
I 1 2 3 4 N 
36 
28 
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Table 4. Electrophysiologic Baseline Variables on Different Days 
P 
Day 1 Day 2 Day 3 F Value 
SCL (ms) 124 + 124 720 2 134 707 k 140 0.46 NS 
BCL (ms) 551 t 45 540 + 41 526 k 55 14.85 <O.OOl 
QTc (ms) 449 ? 40 456 + 42 449 * 50 0.77 NS 
VERP (ms) 245 ? 22 240 + 24 244 f 25 0.43 NS 
Threshold (mA) 1.2 ? 0.4 1.2 ? 0.7 1.1 + 0.3 I.59 NS 
Serum lidocaine post-VT 624 7*4 726 0.97 NS 
(~mol/liter) 
Values are expressed as mean k SD. The therapeutic 
Table 2. 
Baseline electrophysiologic variables were comparable 
from day to day (Table 4), apart from a clinically insignificant 
change in basic pacing cycle length. Nevertheless, they 
manifested a greater range of variability from day to day than 
in the immediate repeat studies (Table 5). 
Discussion 
This study demonstrates that there is significantly less 
baseline variability in mode of induction of ventricular 
tachycardia when repeat inductions are performed within 
one study rather than at intervals of several days. This 
finding indicates that changes in mode of induction of 
ventricular tachycardia after short-term intravenous anti- 
arrhythmic drug administration should be easier to detect 
and less likely to occur by random chance than with long- 
term oral drug testing. This may lead to improved predic- 
tions of antiarrhythmic drug efficacy at electrophysiologic 
testing provided that drugs without significant metabolites 
and with comparable pharmacodynamic effects by either 
route of administration are used. 
Implications for antiarrhythmic drug testing. In this 
study, the probability of immediate variation in mode of 
ventricular tachycardia induction in the drug-free state dif- 
fered depending on the number of extrastimuli required at an 
initial attempt. To allow for this variability, we have pro- 
posed the use of probability matrices with which to predict 
Table 5. Comparison of the Range of Variability of Baseline 
Variables at Immediate Studies Versus Day to Day Studies 
SCL (ms) 
BCL (ms) 
QTc (ms) 
VERP (ms) 
Range of Values Range of Values 
at Immediate at Day to Day 
Studies Studies 
78 t 65 113 + 98 
Median = 0 Median = 30 
25 + 17 42 + 31 
I1 + 10 23 r 14 
p Value 
0.03 
<O.OOl 
<O.Ol 
<O.OOOl 
Values are expressed as mean k SD, except where indicated; abbrevia- 
tions as in Table 2. 
range for lidocaine and abbreviations are as listed in 
the likelihood of changes in ease of arrhythmia induction 
being due to an administered drug (Fig. 2 and 3). 
In these matrices, a change after drug administration in 
ventricular tachycardia induction requirements into the 
shaded area on the right would have only a 5% probability of 
occurring by chance. A move from the line of identity into 
the shaded area on the left would represent a facilitation of 
tachycardia induction that has only a 10% probability of 
occurring by chance. We suggest that the confidence inter- 
vals for detecting a potential adverse drug effect need not be 
as strict as those required to detect antiarrhythmic effect. 
Hence, a 90%, or even lower, probability that ventricular 
tachycardia induction is facilitated by intravenous drug 
administration suggests that the drug is likely to be 
proarrhythmic and is best avoided. If the prediction of 
proarrhythmia is wrong, the drug would then fall into the 
“no significant change” group and therefore is not likely to 
be useful clinically. 
The pattern of immediate variability observed in this 
study showed a regression toward the group mean (2.3 
extrastimuli) in the number of extrastimuli inducing ventric- 
ular tachycardia. Consequently, the least variability in mode 
of tachycardia induction was displayed by those patients 
whose tachycardia was inducible with 2 extrastimuli, where- 
as patients with tachycardia initially inducible with 3 ex- 
trastimuli were likely by chance to require fewer extrastimuli 
in a subsequent induction, and patients with tachycardia 
initially inducible with 1 extrastimulus were likely to require 
more. Therefore, not only the amount of variability but also 
the direction of variability should be considered when at- 
tempting to ascribe changes in mode of tachycardia induc- 
tion to drug therapy. 
Comparison of the immediate and day to day matrices 
clearly shows the wider random scatter around the line of 
identity during the day to day studies. Inspection of the 
probability matrix relating to the day to day data indicates 
that only a change in induction requirements of ~2 extra- 
stimuli would have a 95% probability of being beyond the 
range of chance variability. This corresponds well with the 
JACC Vol. 13, No. 7 
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95% confidence interval of 2 1 extrastimulus for day to day 
variability we have described previously (3). 
Nonetheless, there was still a tendency for patients with 
tachycardia initially induced with 3 extrastimuli to require 
fewer extrastimuli on a subsequent day rather than more. 
Consequently. for the matrix describing day to day data, an 
increase from 3 to 4 in the number of extrastimuli inducing 
ventricular tachycardia after long-term oral drug administra- 
tion would have a 93% probability of representing a drug 
effect. This finding may account for the fact that random 
variability in induction requirements did not seem to impair 
the long-term predictive accuracy of other studies employing 
programmed stimulation for oral drug testing in which an 
upper limit of 3 extrastimuli was used (13-15). 
Variability of tachycardia cycle length. Changes in the 
cycle length of induced ventricular tachycardia after drug 
administration have been used as measured of both anti- 
arrhythmic and proarrhythmic drug effect (16,17). In this 
study, the estimated 95% confidence interval for random 
variability in cycle length of induced monomorphic ventric- 
ular tachycardia was similar for the immediate and day to 
day studies (t33 versus 235 ms). Consequently, prolonga- 
tion or shortening of induced tachycardia cycle length by 
240 ms after drug administration is likely to represent a drug 
effect rather than spontaneous variability. 
Comparison with previous studies. The potential defini- 
tions of drug efficacy and inefficacy outlined in this study are 
applicable only to the particular protocol employed. None- 
theless, the 31% incidence rate of immediate variability in 
mode of ventricular tachycardia induction described in this 
study corresponds well with the 29% incidence rate of 
immediate variability in induction of sustained clinical ven- 
tricular tachycardia over three induction studies that was 
obtained by De Buitleir et al. (18) with a more conventional 
stimulation protocol. 
Most previous studies of the reproducibility of ventricular 
tachycardia induction have examined only variability from 
day to day (1,2,19,20) and have also been limited by the use 
of nonsustained ventricular tachycardia as an end point of 
stimulation (20) and by the inability to confidently quantitate 
variability because of the use of multiple stimulation varia- 
bles (1,2,19,20) and the uncertain ranking of such variables. 
The observation in this study that immediate variability in 
the number of extrastimuli inducing ventricular tachycardia 
tends to regress toward the mean implies that a change in 
induction requirements away from the mean after drug 
administration is likely to represent an antiarrhythmic drug 
effect. This observation may help account for the findings of 
Swerdlow et al. (21), who studied 69 patients with docu- 
mented spontaneous ventricular tachyarrhythmia in whom 
sustained ventricular tachycardia could be induced with a 
maximum of 2 extrastimuli in the drug-free state. In that 
study, the inability to reinduce ventricular tachycardia with 
2 extrastimuli after short-term intravenous drug administra- 
tion identified a group with a relatively good long-term 
outcome even though tachycardia remained inducible in 
many of these patients when a 3rd extrastimulus was added. 
However, a change in mode of tachycardia induction that 
is statistically likely to represent a drug effect does not 
necessarily confer clinical benefit on the patient, Long-term 
clinical studies will be required to validate our proposed 
approach to antiarrhythmic drug testing, and our preliminary 
studies (22,23) suggest that predictions of drug effect made in 
this way have long-term significance. Obviously, the proba- 
bilities used in our probability matrices will have wider 
confidence intervals at the extremities of the range where the 
number of observations was small. Those probabilities based 
on a small number of observations must therefore be used 
cautiously. 
The 95% confidence intervals for random variability in 
cycle length of induced ventricular tachycardias described in 
this study are well within the 100 ms drug-induced change, 
that, together with lack of symptoms during induced tachy- 
cardia, was demonstrated by Waller et al. (16) to reduce the 
risk of subsequent sudden death. In fact, this current study 
would suggest that changes in tachycardia cycle length of 
even 40 ms may be significant, although it is not known 
whether they are sufficient to confer clinical benefit. 
Possible causes for reduced variability at immediate stud- 
ies. It is likely that variation in autonomic tone is more 
marked from day to day than within one study. Certainly, in 
this study, most basic electrophysiologic variables such as 
sinus cycle length, ventricular effective refractory period 
and QT interval varied over a significantly wider range from 
day to day than at multiple inductions within one study. 
Although some acceleration of heart rate and, consequently, 
basic pacing rate was observed during the immediate repeat 
studies. this acceleration was not sufficient to affect the 
effective refractory period or ease of tachycardia induction. 
This finding is in keeping with the data of Morady et al. (24), 
who suggested that a 15 min interval between arrhythmia 
inductions after cardioversion should be sufficient to allow 
transiently elevated catecholamine levels to return to their 
level at rest. 
The position of the pacing catheter was not altered for our 
immediate studies, whereas in the day to day studies a new 
catheter was inserted each day. This factor may also have 
contributed to the reduced variability observed in the single 
day studies. 
Potential limitations of electrophysioiogic intravenous drug 
testing. The potential advantage that reduced intrastudy 
variability may confer on the predictive accuracy of short- 
term electrophysiologic drug testing may be offset by several 
possible confounding factors. Obviously, the use of drugs 
whose long-term oral effects differ from their short-term 
intravenous effects would impair the predictive value of this 
technique. For instance, the long-term effects of oral amio- 
darone appear to differ from the effects after short-term 
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intravenous administration (25,26). Such a discrepancy be- 
tween intravenous and oral effects is also possible for any 
antiarrhythmic drug that has active metabolites (27). 
Second, the abrupt alterations in autonomic tone or 
hemodynamic status that are possible after rapid intrave- 
nous loading may produce an artificially stressful testing 
situation that may not be an appropriate model for the effects 
of long-term oral therapy. The lack of stability of serum drug 
levels after intravenous bolus injection may also lead to a 
lack of correlation between intravenous and oral therapy. 
Furthermore, long-term drug eficacy and ineficacy are 
not necessarily dejined solely by a drug’s effect on arrhyth- 
mia induction (28). For example, a drug that reduces the 
number and rate of potential tachycardia triggering beats 
may reduce the risk of spontaneous arrhythmia occurrence 
without altering induction of tachycardia (29). Nonetheless, 
in many studies, programmed stimulation has been found to 
be of value in predicting the outcome of long-term anti- 
arrhythmic drug therapy for ventricular tachycardia (4-6,8- 
10). Furthermore, several of these studies (8-10) employed 
an intravenous route of drug administration. Obviously, 
follow-up studies will be required to assess whether the 
potential limitations of short-term intravenous drug admin- 
istration are outweighed by the benefits of improved repro- 
ducibility. 
Conclusions. The mode of induction of ventricular tachy- 
cardia varies less frequently at repeat inductions within one 
study than from day to day. Use of a probability matrix 
allowing for chance variability in mode of tachycardia induc- 
tion at short-term electrophysiologic intravenous drug test- 
ing may permit better and more sensitive assessment of both 
antiarrhythmic and proarrhythmic drug effects. 
We gratefully acknowledge the expert typographical assistance of Marie 
Forster in the preparation of this manuscript. 
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